Use of Proton Pump Inhibitors and Risk of Dementia or Alzheimer's Disease：a Meta-analysis

doi:10.12114/j.issn.1007-9572.2018.00.308

Abstract

Abstract: Background　Proton pump inhibitors （PPIs） are drugs that recognized for the treatment of most diseases related to abnormal gastric acid secretion，which are widely used among the elderly.Some prospective studies have indicated that PPI may increase the risk of dementia.However，the results of those studies were inconsistent and controversial.Therefore，it is necessary to determine whether PPI can increase the risk of dementia or Alzheimer's disease （AD） in elderly people.Objective　To evaluate the association between PPI and the risk of dementia or AD systematically.Methods　Prospective cohort studies and case-control studies that reported risk of dementia or AD causing by PPI were searched in PubMed，EMBase and Cochrane Library databases from their inception to February 2018.The Review Manager 5.3 software and STATA 12.0 software were used for Meta analysis.Results　A total of 9 studies were included，including 7 cohort studies and 2 case-control studies，with a total of 622 793 patients.Findings of Meta analysis showed that there was no statistically significant association between PPI use and risk of dementia〔RR=1.17，95%CI（0.89，1.55），P=0.26〕 or AD 〔RR=0.94，95%CI（0.89，1.00），P=0.06〕.Conclusion　Current research shows that there was no correlation between PPI use and the risk of dementia or AD，and using PPI will not increase the risk of having dementia or AD.

Key words: Dementia, Alzheimer disease, Proton pump inhibitors, Cohort studies, Case-control studies, Meta-analysis

摘要： 背景　质子泵抑制剂（PPI）是一种公认的用于治疗大多数与胃酸分泌异常有关疾病的药物，在老年人群中应用十分广泛。部分前瞻性研究指出服用PPI可能会增加老年人痴呆发生的风险。然而，这些研究的结果各异且存在争议性。故确定PPI能否引起老年人患痴呆或阿尔茨海默病（AD）风险增加十分必要。目的　系统评价PPI与痴呆或AD发病风险的相关性。方法　计算机检索PubMed、EMBase、Cochrane Library数据库有关PPI引起痴呆或AD发病风险的前瞻性队列研究及病例对照研究，检索时间从建库至2018年2月。使用Review Manager 5.3软件及STATA 12.0软件进行Meta分析。结果　共纳入9篇文献，其中队列研究7篇，病例对照研究2篇，共622 793例患者。Meta分析结果显示，PPI与痴呆发病风险无相关性〔相对危险度（RR）=1.17，95%CI（0.89，1.55），P=0.26〕；PPI与AD发病风险无相关性〔RR=0.94，95%CI（0.89，1.00），P=0.06〕。结论　目前研究表明，PPI与痴呆或AD发病风险无相关性，服用PPI不会增加痴呆或AD的发病风险。但研究结论不一致，还需要更多高质量文献进行支持。

关键词: 痴呆, 阿尔茨海默病, 质子泵抑制剂, 队列研究, 病例对照研究, Meta分析

YU Sisi,LUO Zheng,LI Miaomiao, et al. Use of Proton Pump Inhibitors and Risk of Dementia or Alzheimer's Disease：a Meta-analysis　[J]. Chinese General Practice, 2019, 22(23): 2861-2865. DOI: 10.12114/j.issn.1007-9572.2018.00.308.
喻思思,罗拯,李苗苗等. 质子泵抑制剂与痴呆或阿尔茨海默病发病风险相关性的Meta分析[J]. 中国全科医学, 2019, 22(23): 2861-2865. DOI: 10.12114/j.issn.1007-9572.2018.00.308.

References

［1］SOSA-ORTIZ A L，ACOSTA-CASTILLO I，PRINCE M J.Epidemiology of dementias and Alzheimer's disease［J］．Arch Med Res，2012，43（8）：600-608．DOI：10.1016/j.arcmed.2012.11.003.
［2］GOEDERT M，SPILLANTINI M G.A century of Alzheimer's disease［J］．Science，2006，314（5800）：777-781．DOI：10.1126/science.1132814.
［3］CATINDIG J A，VENKETASUBRAMANIAN N，IKRAM M K，et al．Epidemiology of dementia in Asia：insights on prevalence，trends and novel risk factors［J］．J Neurol Sci，2012，321（1/2）：11-16．DOI：10.1016/j.jns.2012.07.023.
［4］WISE J.Proton pump inhibitors may be linked to dementia risk［J］．BMJ，2016，352（6）：i972．DOI：10.1136/bmj.i972.
［5］HAENISCH B，VON HOLT K，WIESE B，et al．Risk of dementia in elderly patients with the use of proton pump inhibitors［J］．Eur Arch Psychiatry Clin Neurosci，2015，265（5）：419-428．DOI：10.1007/s00406-014-0554-0.
［6］GOMM W，VON HOLT K，THOME F，et al．Association of proton pump inhibitors with risk of dementia：a pharmacoepidemiological claims data analysis［J］．JAMA Neurol，2016，73（4）：410-416．DOI：10.1001/jamaneurol.2015.4791.
［7］SIMONSON W.Do proton pump inhibitors cause dementia?［J］．Geriatr Nurs，2016，37（3）：228-229．DOI：10.1016/j.gerinurse.2016.04.009.
［8］SCHOENFELD A J，GRADY D.Adverse effects associated with proton pump inhibitors［J］．JAMA Intern Med，2016，176（2）：172-174．DOI：10.1001/jamainternmed.2015.7927.
［9］STANG A.Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses［J］．Eur J Epidemiol，2010，25（9）：603-605．DOI：10.1007/s10654-010-9491-z.
［10］GRAY S L，WALKER R L，DUBLIN S，et al．Proton pump inhibitor use and dementia risk：prospective population-based study［J］．J Am Geriatr Soc，2018，66（2）：247-253．DOI：10.1111/jgs.15073.
［11］HERGHELEGIU A M，PRADA G I，NACU R.Prolonged use of proton pomp inhibitors and cognitive function in older adults［J］．FARMACIA，2016，64（2）：262-267.
［12］TAI S Y，CHIEN C Y，WU D C，et al．Risk of dementia from proton pump inhibitor use in Asian population：a nationwide cohort study in Taiwan［J］．PLoS One，2017，12（2）：e0171006．DOI：10.1371/journal.pone.0171006.
［13］GOLDSTEIN F C，STEENLAND K，ZHAO L，et al．Proton pump inhibitors and risk of mild cognitive impairment and dementia［J］．J Am Geriatr Soc，2017，65（9）：1969-1974．DOI：10.1111/jgs.14956.
［14］JUNTUNEN H，TAIPALE H，TANSKANEN A，et al．Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease［J］．Eur J Clin Pharmacol，2017，73（9）：1149-1158．DOI：10.1007/s00228-017
-2273-8.
［15］TAIPALE H，TOLPPANEN A M，TIIHONEN M，et al．No association between proton pump inhibitor use and risk of Alzheimer's disease［J］．Am J Gastroenterol，2017，112（12）：1802-1808．DOI：10.1038/ajg.2017.196.
［16］BOOKER A，JACOB L E，RAPP M，et al．Risk factors for dementia diagnosis in German primary care practices［J］．Int Psychogeriatr，2016，28（7）：1059-1065．DOI：10.1017/S1041610215002082.
［17］WIJARNPREECHA K，THONGPRAYOON C，PANJAWATANAN P，et al．Proton pump inhibitors and risk of dementia［J］．Ann Transl Med，2016，4（12）：240-246．DOI：10.21037/atm.2016.06.14.
［18］PARK S K，BAEK Y H，PRATT N，et al．The uncertainty of the association between proton pump inhibitor use and the risk of dementia：prescription sequence symmetry analysis using a Korean healthcare database between 2002 and 2013［J］．Drug Saf，2018，41（6）：615-624．DOI：10.1007/s40264-018-0638-2.
［19］QUERFURTH H W，LAFERLA F M.Alzheimer's disease［J］．N Engl J Med，2010，362（4）：329-344．DOI：10.1056/nejmra0909142.
［20］BADIOLA N，ALCALDE V，PUJOL A，et al．The proton-pump inhibitor lansoprazole enhances amyloid beta production［J］．PLoS One，2013，8（3）：e58837．DOI：10.1371/journal.pone.0058837.
［21］KULLER L H.Do proton pump inhibitors increase the risk of dementia?［J］．JAMA Neurol，2016，73（4）：379-381．DOI：10.1001/jamaneurol.2015.4931.
［22］DE STROOPER B，ANNAERT W.Proteolytic processing and cell biological functions of the amyloid precursor protein［J］．J Cell Sci，2000，113（Pt 11）：1857-1870.
［23］王聪，张杰文.AD患者血清Hcy叶酸及维生素B12与认知功能减退的关系研究［J］．中国实用神经疾病杂志，2017，20（19）：43-47．DOI：10.3969/j.issn.1673-5110.2017.19.010.
WANG C，ZHANG J W.Correlation of cognitive impairment with vitamin B12 and folic acid and homocysteine in elderly dementia patients［J］．Chinese Journal of Practical Nervous Diseases，2017，20（19）：43-47．DOI：10.3969/j.issn.1673-5110.2017.19.010.
［24］胡尧，郭启浩，岑屹，等．老年痴呆患者认知功能与维生素B12及叶酸的相关性［J］．检验医学，2017，32（4）：284-289．DOI：10.3969/j.issn.1673-8640.2017.04.009.
HU Y，GUO Q H，CEN Y，et al．Correlations of cognitive impairment with vitamin B12 and folic acid in elderly dementia patients［J］．Laboratory Medicine，2017，32（4）：284-289．DOI：10.3969/j.issn.1673-8640.2017.04.009.
［25］PASINA L，NOBILI A，TETTAMANTI M，et al．Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly［J］．Eur J Intern Med，2011，22（2）：205-210．DOI：10.1016/j.ejim.2010.11.009.
［26］JUNG S B，NAGARAJA V，KAPUR A，et al．Association between vitamin B12 deficiency and long-term use of acid lowering agents：a systematic review and meta-analysis［J］．Intern Med J，2015，45（4）：409-416．DOI：10.1111/imj.12697.
［27］WOLTERS M，STR?HLE A，HAHN A.Cobalamin：a critical vitamin in the elderly［J］．Prev Med，2004，39（6）：1256-1266．DOI：10.1016/j.ypmed.2004.04.047.

[1]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[2]	ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006.
[3]	WEN Wen, ZHANG Kainan, CHEN Yulan, LI Yu, ZHANG Xiangyang. Correlation of Metabolic Indexes as Predictors with Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3740-3747.
[4]	DENG Jingjing, LI Xia, XUE Qian, DENG Lihua, WANG Jingtong. The Efficacy of Continuous Airway Positive Pressure Ventilation on OSA Complicated with GERD: an Observational Study [J]. Chinese General Practice, 2023, 26(30): 3753-3758.
[5]	ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621.
[6]	XU Zhe, ZHANG Jinxia, ZHANG Xiuhong, XIE Kaihong. Relationship between Sleep Duration and All-cause Mortality in Middle-aged and Older Adults [J]. Chinese General Practice, 2023, 26(28): 3507-3512.
[7]	LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422.
[8]	CHEN Lunwen, ZHOU Yang, YAN Guodong, SHEN Yi, SUN Chen, CAI Wanli, CHU Minjie, XIAO Jing. Risk of Malignant Tumor in Patients with Type 2 Diabetes: a Prospective Population-based Study [J]. Chinese General Practice, 2023, 26(26): 3238-3245.
[9]	WANG Xinyuan, LIU Yanli, ZHOU Lijun, ZHANG Qi, WEI Qifei, YAN Xingyu, LUO Jiao, LIU Xiaofei. Advances in Resistance to Care in Patients with Dementia [J]. Chinese General Practice, 2023, 26(22): 2809-2815.
[10]	WANG Xinyuan, WANG Xiaolei, LIU Yanli, AN Ran, LUO Jiao, LIU Xiaofei, LI Yangyang, HU Chongdie, HOU Fuwen. Advances in Evaluation Tools for Resistiveness to Care in Patients with Dementia [J]. Chinese General Practice, 2023, 26(22): 2816-2822.
[11]	YU Yanxue, BAI Ruyu, YU Wenlong, GUO Xia, WU Li'e. Occurrence Status and Influencing Factors of Cognitive Dysfunction in Population Aged 60 and Above [J]. Chinese General Practice, 2023, 26(21): 2581-2588.
[12]	HE Manlan, YUAN Ping, HE Lei, CHEN Lu. Meta-analysis of Risk Factors for Urinary Tract Infection in Neurogenic Bladder [J]. Chinese General Practice, 2023, 26(21): 2659-2665.
[13]	ZHAO Zewei, KANG Ning, GUO Fengli, WANG Zhongyu, ZHENG Xiangqian. Effect of Aurora Kinase A Expression on Biochemical Cure in Patients after Medullary Thyroid Cancer Resection [J]. Chinese General Practice, 2023, 26(20): 2508-2512.
[14]	SU Afang, ZHU Guoling, ZHANG Yunshui, CHEN Shuohua, ZHAO Xiujuan, YANG Wenhao, WANG Yinjie, WANG Fengfei, XIN Yingying, WU Shouling, ZHANG Jie, JIANG Xiaozhong. Association between Baseline Fasting Plasma Glucose Levels and Risk of Acute Pancreatitis in Non-obese Population: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(18): 2203-2208.
[15]	ZHAI Leilei, ZHAO Shupeng, YAO Ping. Meta-analysis of the Relationship between Dietary Inflammatory Index and Upper Gastrointestinal Cancer Risks [J]. Chinese General Practice, 2023, 26(18): 2286-2292,2300.